Volume 19, Number 3—March 2013
Research
Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010
Table 5
Subgroup | No. deaths without a vaccination program (range) | No. deaths prevented due to a vaccination program (range) | No. doses administered to avoid 1 death (range) |
---|---|---|---|
6 mo–9 y | 759 (538–1,117) | 9 (5–15) | 3,087,138 (1,745,154–5,761,939) |
10–24 y, (10–17 all, 18–24 NP) | 1,028 (729–1,514) | 30 (20–50) | 525,012 (319,229–814,797) |
Pregnant 18–64 y | 533 (378–789) | 37 (25–60) | 64,787 (40,177–96,492) |
25–64 y, HR, NP | 3,077 (2,182–4,533) | 84 (54–139) | 109,638 (66,300–171,951) |
25–64 y, HCW, non-HR, NP | 1,175 (833–1,735) | 53 (35–87) | 117,312 (71,786–179,325) |
25–64, contact with <6 mo, non-HCW, non-HR, NP | 766 (544–1,128) | 18 (12–30) | 112,945 (68,351–175,889) |
25–64 y, noncontact with <6 mo, non-HCW, non-HR, NP | 3,792 (2,692–5,578) | 52 (32–86) | 297,838 (177,870–479,999) |
>65 y |
1,653 (1,173–2,433) |
32 (20–53) |
339,494 (204,961–533,711) |
Total | 12,783 (9,069–18,826) | 315 (201–520) | 281,305 (170,343–439,832) |
* All values are estimates. Vaccinations beginning at week 40 with a distribution of the vaccines as outlined in Table 2. NP, not pregnant; HR, high risk; HCW, health care worker; contact, household contacts and caregivers of children <6 mo of age.
1Current affiliation: Merck & Co., Inc., Lansdale, Pennsylvania, USA.
Page created: February 12, 2013
Page updated: February 12, 2013
Page reviewed: February 12, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.